Mar

    Irreparable Harm in Lanham Act False Advertising Litigation

    12 PM EST

    The panel will recent cases such as Third Circuit’s August 26, 2014 decision in Ferring Pharmaceuticals v. Watson Pharmaceuticals and the Herb Reed case in the Ninth Circuit --- these case confirms not only the new law that plaintiffs are not entitled to a presumption of irreparable harm in Lanham Act false advertising cases, the case poses a more fundamental question: How exactly does a Lanham Act plaintiff demonstrate irreparable harm? Even with a direct comparative and literally false advertisement, a Lanham Act plaintiff still must make a “clear showing” of irreparable harm in order to obtain a preliminary injunction. Such a showing must comply with the requirement that the plaintiff

    Moderator:
    *Sherrie Schiavetti, Kelley Drye

    Speakers: 
    *
    Roger Colaizzi, Venable LLP
    *David Bernstein, Debevoise & Plimpton LLP
    *Rebecca Tushnet, Georgetown University

     

    FREE:  Antitrust Section Members, Government, Nonprofit Employees and Students
    $25.00:  Other Non-Members

    Learn about Section Membership or call 800-285-2221 to join with source code:  RAT14IP25.  Instructions for accessing the live program will be provided in a confirmation email.  For this and all upcoming events visit:  http://AmBar.org/ATEvents.

    CLE
    The ABA is not seeking CLE credit for this program.

    Audio Archive
    Provided all releases are obtained, MP3 recordings of this program will be available to Section members on the Committee Program Audio page.

     


     

    $25
    NON-MEMBERS
    $10
    MEMBERS
    $0
    SECTION MEMBERS
    Register Now *Additional discounts may apply at checkout

    Log In to view your rate

    Irreparable Harm in Lanham Act False Advertising Litigation

    Event Details

    Format

    Teleconference

    Date

    Mar 06, 2015

    2015-03-06T12:00:00-05:00 2015-03-06T13:00:00-05:00 Irreparable Harm in Lanham Act False Advertising Litigation

    The panel will recent cases such as Third Circuit’s August 26, 2014 decision in Ferring Pharmaceuticals v. Watson Pharmaceuticals and the Herb Reed case in the Ninth Circuit --- these case confirms not only the new law that plaintiffs are not entitled to a presumption of irreparable harm in Lanham Act false advertising cases, the case poses a more fundamental question: How exactly does a Lanham Act plaintiff demonstrate irreparable harm? Even with a direct comparative and literally false advertisement, a Lanham Act plaintiff still must make a “clear showing” of irreparable harm in order to obtain a preliminary injunction. Such a showing must comply with the requirement that the plaintiff

    Moderator:
    *Sherrie Schiavetti, Kelley Drye

    Speakers: 
    *
    Roger Colaizzi, Venable LLP
    *David Bernstein, Debevoise & Plimpton LLP
    *Rebecca Tushnet, Georgetown University

     

    FREE:  Antitrust Section Members, Government, Nonprofit Employees and Students
    $25.00:  Other Non-Members

    Learn about Section Membership or call 800-285-2221 to join with source code:  RAT14IP25.  Instructions for accessing the live program will be provided in a confirmation email.  For this and all upcoming events visit:  http://AmBar.org/ATEvents.

    CLE
    The ABA is not seeking CLE credit for this program.

    Audio Archive
    Provided all releases are obtained, MP3 recordings of this program will be available to Section members on the Committee Program Audio page.

     


     

    Sponsors

    Section of Antitrust Law

    Co-sponsors

    Consumer Protection

    Related Products

    Related On-Demand CLE